|
English
|
正體中文
|
简体中文
|
0
|
|
???header.visitor??? :
53139731
???header.onlineuser??? :
333
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"yan wl"???jsp.browse.items-by-author.description???
Showing items 1-5 of 5 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國家衛生研究院 |
2021-10 |
Activation of GM-CSF and TLR2 signaling synergistically enhances antigen-specific antitumor immunity and modulates the tumor microenvironment
|
Yan, WL;Wu, CC;Shen, KY;Liu, SJ |
| 國家衛生研究院 |
2020-03-28 |
Liposomal TLR9 agonist combined with TLR2 agonist-fused antigen can modulate tumor microenvironment through dendritic cells
|
Shen, KY;Liu, HY;Yan, WL;Wu, CC;Lee, MH;Leng, CH;Liu, SJ |
| 國家衛生研究院 |
2017-03 |
Recent progress in GM-CSF-based cancer immunotherapy
|
Yan, WL;Shen, KY;Tien, CY;Chen, YA;Liu, SJ |
| 國家衛生研究院 |
2015-11 |
Gemcitabine synergistically enhances anti-tumor effects of recombinant immunogen-based cancer immunotherapy
|
Liu, SJ;Chang, LS;Yan, WL;Yeh, YC;Leng, CH |
| 國家衛生研究院 |
2015-10 |
Gemcitabine enhances antitumor efficacy of recombinant lipoimmunogen-based immunotherapy
|
Chang, LS;Yan, WL;Chang, YW;Yeh, YC;Chen, HW;Leng, CH;Liu, SJ |
Showing items 1-5 of 5 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
